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Introduction 
Male breast cancer (MBC) is rare and poorly 
characterized. As compared to the female 
counterpart, it is a distinct disease regarding 
clinicopathological and molecular features. We 
report herein a case of MBC revealed by skin 
involvement to draw physicians’ attention to this 
disease and its severity. 
 
Case Synopsis 
A 50-year-old man, who had no family breast cancer 
history, was evaluated by our department for three 
painless purple nodules of the right areola (Figure 
1). The patient reported that the nodules appeared 4 
years before his consultation. The clinical 
examination revealed significant induration 
underlying the areola (Figure 1) with painless 
ipsilateral axillary lymphadenopathy of 1cm. We 
performed a skin biopsy, which revealed an invasive 
breast cancer grade 2 with direct pagetoid extension 
into epidermis (Figure 2). The tumor was estrogen-
receptor-positive (ER+) and progesterone-receptor-
positive (PR+), (Figure 3). The patient underwent 
mastectomy with lymph node dissection. Histology 
confirmed the grade 2 invasive breast cancer with 
axillary lymph node involvement (T4bN3M0). He 
underwent radiation therapy and hormonal therapy. 
 
Case Discussion 
Male breast cancer is a rare disease (0.5 to 1% of 
breast cancers). The mean age of occurrence is 5 
years later than in women. The risk of developing 
breast cancer in males is higher in patients with a 
history of familial breast cancer in a first-degree 
relative [1]. Mutations in high-penetrance BRCA1 and  
Abstract 
Male breast cancer is a rare disease with an unknown 
etiopathogenesis. We report a case of a 50-year-old 
man with a breast cancer revealed by skin 
involvement. 
Figure 1. Clinical images showing purple nodules of the right 
areola.
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Figure 2. H&E pathology images showing A) adenocarcinoma proliferation in dermis, 100×, B) cribriform carcinoma of the breast, 200×, 
C) cribriform carcinoma of the breast, 400×, D) Pagetoid extension of the tumor to the epidermis 400×. 
A B
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Figure 3. Immunohistological images showing A) estrogen-receptor positivity in 100% of cells, 100×, B) progesterone-receptor positivity 
in 98% of cells, 200×. 
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BRCA2 genes are also risk factors [2]. Occupational 
risks include high temperature environments and 
exhaust fumes. Hyperestrogenization resulting from 
Klinefelter syndrome, gonadal dysfunction, obesity, 
or excess alcohol all increase risk, as does exposure 
to radiation [3]. 
Male breast cancer is usually revealed by breast 
nodules and nipple retraction or secretions, but 
rarely by areolar nodules. Delay in diagnosis can 
result from ignorance of the existence of breast 
cancer among men. 
Men do not have lobules; the mean histological type 
is invasive ductal carcinoma (85–95%). Estrogen-
receptor positivity has been reported in more than 
90% of cases, with 92–96% being progesterone-
receptor positive [4]. 
The standard treatment for invasive male breast 
cancer is wide excision with axillary dissection 
(clearance or sentinel node biopsy). Indications for 
radiotherapy are similar to female breast cancer. 
Because 90% of tumors are estrogen receptor 
positive, tamoxifen is standard adjuvant therapy. 
 
Conclusion 
Skin involvement can reveal rare and severe 
diseases. This case emphasizes the need to consider 
the diagnosis of breast malignancy for patients 
presenting with nipple nodules, even in men. 
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